Fig 1: CLIPT controls MCU degradation.a Doxycycline (doxy) treatment represses transcription of MCU-Flag. MCU-Flag persists after Complex I inhibition (rotenone) but not Complex III (antimycin A) or IV (sodium azide). b MCU-Flag stabilization induced by NTD peptide. c Design of rapamycin (Rapa)-induced dimerization experiment to test if MCU-Complex I interactions dictate MCU degradation. d Immunocytochemistry reveals co-localization of FRB-MCU, NDUFA10-FKBP, and mito-FKBP with mitochondrial markers CoxIV or ATP5F1. e With replacement of NTD with FRB, MCU only binds FKBP-tagged NDUFA10 in the presence of 100 nM rapamycin. Mito-FKBP-HA is a control. f FRB-MCU is stable in the absence or presence of rapamycin when cells co-express mito-FKBP-HA control, but rapidly degraded when rapamycin induces Complex I-binding in NDUFA10-FKBP-HA expressing cells. Images are representative of 3 (a, b, f) or 2 (d, e) separate trials. Source data are provided as a Source Data file.
Fig 2: Mitochondrial gene expression and function after four exposures. Mitochondrial electron transport chain maximal activities defined as the amount of substrate consumed per minute per ng or mg of protein for A complex I, B complex II, C complex III, D complex IV, and E complex V at day four exposure (n = 4, each group). F Using Ingenuity Pathway Analysis (IPA), mitochondrial genes that were differentially expressed in the oxidative phosphorylation pathway are displayed for co-exposure. Genes colored red have statistically increased transcription, genes colored green have statistically decreased transcription, and genes colored grey have no change in transcription, compared to the air control group. The shape of the genes is not indicative of function or pathology. Coloring of the entire complex, i.e. complex I, II, III, IV, and V, indicates global increase/decrease of expression of the entire complex. F The maximal activities of ETC complexes I–V are displayed above each of the corresponding complex units. G Western blot of ATP5F1 and quantification. H Electron flow was measured in co-exposure compared to the sham group for complexes I–IV. I Total ATP content was quantified by day and group for CB, O3, and CB + O3 groups. Day 1 (n = 4, each group) and Day 4 (n = 4, each group). Differences between groups were considered statistically significant if P ≤ 0.05, denoted by *. Data are presented as the mean ± standard error of the mean (SEM), when appropriate. Sham—4 = filtered air exposed for 4 days, CB—4 = 10 mg/m3 CB exposure for 3 h repeated four times (24 h apart), O3—4 = 2 ppm O3 exposure for 3 h repeated four times (24 h apart), CB + O3—4 = 10 mg/m3 CB and 2 ppm O3 inhalation co-exposure for 3 h repeated four times (24 h apart), OCR oxygen consumption rate
Supplier Page from Abcam for Anti-ATP5F1 antibody [9D1BC4]